Hein D, Millner L
Expert Opin Drug Metab Toxicol. 2020; 17(1):9-21.
PMID: 33094670
PMC: 7790970.
DOI: 10.1080/17425255.2021.1840551.
Wadelius M, Eriksson N, Kreutz R, Bondon-Guitton E, Ibanez L, Carvajal A
Clin Pharmacol Ther. 2017; 103(5):843-853.
PMID: 28762467
PMC: 5947520.
DOI: 10.1002/cpt.805.
Karlsson E, Molin L, Norlander B, Sjoqvist F
Br J Clin Pharmacol. 2012; 1(6):467-75.
PMID: 22454932
PMC: 1402529.
DOI: 10.1111/j.1365-2125.1974.tb01696.x.
Vree T, OREILLY W, Hekster Y, Damsma J, van der Kleijn E
Clin Pharmacokinet. 1980; 5(3):274-94.
PMID: 7389236
DOI: 10.2165/00003088-198005030-00006.
Karim A, Elfellah M, Evans D
J Med Genet. 1981; 18(5):325-30.
PMID: 7328611
PMC: 1048751.
DOI: 10.1136/jmg.18.5.325.
Drug metabolites in renal failure: pharmacokinetic and clinical implications.
Verbeeck R, Branch R, Wilkinson G
Clin Pharmacokinet. 1981; 6(5):329-45.
PMID: 7037261
DOI: 10.2165/00003088-198106050-00001.
The association of the slow acetylator phenotype with bladder cancer.
Evans D, Eze L, Whibley E
J Med Genet. 1983; 20(5):330-3.
PMID: 6644762
PMC: 1049143.
DOI: 10.1136/jmg.20.5.330.
Survey of the human acetylator polymorphism in spontaneous disorders.
Evans D
J Med Genet. 1984; 21(4):243-53.
PMID: 6387123
PMC: 1049291.
DOI: 10.1136/jmg.21.4.243.
Sulphasalazine and male infertility: reversibility and possible mechanism.
Toovey S, Hudson E, HENDRY W, Levi A
Gut. 1981; 22(6):445-51.
PMID: 6114897
PMC: 1419267.
DOI: 10.1136/gut.22.6.445.
A filter paper method for determining isoniazid acetylator phenotype.
Weber W, Brenner W
Am J Hum Genet. 1974; 26(4):467-73.
PMID: 4841635
PMC: 1762588.
Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.
Hearse D, Weber W
Biochem J. 1973; 132(3):519-26.
PMID: 4724587
PMC: 1177616.
DOI: 10.1042/bj1320519.
Simplified method for determining acetylator phenotype.
Schroder H
Br Med J. 1972; 3(5825):506-7.
PMID: 4403571
PMC: 1785779.
DOI: 10.1136/bmj.3.5825.506.
The metabolism of salicylazosulphapyridine in ulcerative colitis. I. The relationship between metabolites and the response to treatment in inpatients.
Das K, Eastwood M, MCMANUS J, Sircus W
Gut. 1973; 14(8):631-41.
PMID: 4147555
PMC: 1412758.
DOI: 10.1136/gut.14.8.631.
The relationship between the acetylator and the sparteine hydroxylation polymorphisms.
Harmer D, Evans D, Eze L, Jolly M, Whibley E
J Med Genet. 1986; 23(2):155-6.
PMID: 3712391
PMC: 1049571.
DOI: 10.1136/jmg.23.2.155.
Effects of salbutamol on the absorption and disposition of sulphamethoxazole in adult volunteers.
Adebayo G, Ogundipe T
Eur J Drug Metab Pharmacokinet. 1989; 14(1):57-60.
PMID: 2759134
DOI: 10.1007/BF03190842.
Comparison of the single dose pharmacokinetics of sulphasalazine in rheumatoid arthritis and inflammatory bowel disease.
Astbury C, Taggart A, Juby L, Zebouni L, Bird H
Ann Rheum Dis. 1990; 49(8):587-90.
PMID: 1975737
PMC: 1004169.
DOI: 10.1136/ard.49.8.587.
Polymorphic acetylation of nitrazepam.
Karim A, Evans D
J Med Genet. 1976; 13(1):17-9.
PMID: 775091
PMC: 1013342.
DOI: 10.1136/jmg.13.1.17.
Pharmacokinetics of N1-acetyl- and N4-acetylsulphamethoxazole in man.
Vree T, Hekster Y, Damsma J, van der Kleijn E, OREILLY W
Clin Pharmacokinet. 1979; 4(4):310-9.
PMID: 487686
DOI: 10.2165/00003088-197904040-00004.
Clinical pharmacokinetics of isoniazid.
Weber W, Hein D
Clin Pharmacokinet. 1979; 4(6):401-22.
PMID: 391461
DOI: 10.2165/00003088-197904060-00001.
Disease and acetylation polymorphism.
Lunde P, Frislid K, Hansteen V
Clin Pharmacokinet. 1977; 2(3):182-97.
PMID: 328206
DOI: 10.2165/00003088-197702030-00003.
